Impact of more detailed categorization of shrinkage or progression ratio at initial imaging response after sorafenib treatment in advanced hepatocellular carcinoma patients

BACKGROUND: Sorafenib therapy improves survival in unresectable hepatocellular carcinoma (HCC) patients without an objective response. The present study investigated whether the initial imaging response might be a prognostic indicator after administration of sorafenib therapy in HCC patients. PATIEN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Wada, Yoshiyuki, Takami, Yuko, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636094/
https://ncbi.nlm.nih.gov/pubmed/26586953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S94246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados